Millennium Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-419,495
Closed -$293K 6955
2023
Q1
$293K Buy
419,495
+4,225
+1% +$3.42K ﹤0.01% 4921
2022
Q4
$341K Buy
415,270
+41,760
+11% +$41.2K ﹤0.01% 5007
2022
Q3
$388K Sell
373,510
-327,277
-47% -$523K ﹤0.01% 5173
2022
Q2
$1.15M Buy
+700,787
New +$1.46M ﹤0.01% 4244
2022
Q1
Sell
-22,192
Closed -$106K 7782
2021
Q4
$106K Sell
22,192
-52,412
-70% -$338K ﹤0.01% 6231
2021
Q3
$565K Buy
+74,604
New +$477K ﹤0.01% 5235
2021
Q2
Sell
-137,047
Closed -$1.07M 7309
2021
Q1
$1.07M Sell
137,047
-53,988
-28% -$540K ﹤0.01% 4159
2020
Q4
$1.76M Buy
+191,035
New +$1.66M ﹤0.01% 3329
2020
Q3
Sell
-66,223
Closed -$434K 4935
2020
Q2
$434K Sell
66,223
-210,182
-76% -$759K ﹤0.01% 3487
2020
Q1
$517K Sell
276,405
-22,426
-8% -$59.1K ﹤0.01% 2861
2019
Q4
$562K Sell
298,831
-191,330
-39% -$319K ﹤0.01% 3312
2019
Q3
$696K Sell
490,161
-57,313
-10% -$125K ﹤0.01% 3058
2019
Q2
$1.54M Buy
547,474
+210,655
+63% +$839K ﹤0.01% 2559
2019
Q1
$1.61M Sell
336,819
-6,227
-2% -$30.6K ﹤0.01% 2551
2018
Q4
$1.46M Sell
343,046
-202,448
-37% -$1.56M ﹤0.01% 2396
2018
Q3
$5.97M Buy
545,494
+10,643
+2% +$125K 0.01% 1673
2018
Q2
$8.72M Buy
+534,851
New +$7.74M 0.01% 1415

Other funds holding SURF

Millennium Management's SURF Position: Q2 2023 in Review

Millennium Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 419,495 shares — an estimated $293K sold.

Millennium Management first reported a position in SURF in Q2 2018 and held it in 17 quarters. The position peaked at $8.72M in Q2 2018. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Millennium Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Millennium Management sold 419,495 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $293K.
  • Millennium Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
  • Millennium Management's Surface Oncology, Inc. Common Stock position peaked at $8.72M in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.